Agios Pharmaceuticals
AGIO
161 hedge funds and large institutions have $3.35B invested in Agios Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 28 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 43
36% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 28
27% more capital invested
Capital invested by funds: $2.64B → $3.35B (+$711M)
7% more funds holding
Funds holding: 151 → 161 (+10)
40% less call options, than puts
Call options by funds: $28.1M | Put options by funds: $46.5M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$116M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$116M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$37M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$17.7M |
| 5 |
CC
Cannell & Co
New York
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$39.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25.4M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$16.7M |
| 4 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
-$12M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$9.46M |
AGIO Hedge Fund Activity: Q2 2015 in Review
161 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q2 2015, worth a combined $3.35B — up 27% from $2.64B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new AGIO positions and 28 closed out — a net gain of 10 holders — while 61 added to existing stakes and 43 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $116M. The largest seller was BlackRock Advisors, cutting an estimated $39.5M.
- 161 institutional investors held Agios Pharmaceuticals (AGIO) as of Q2 2015, up from 151 in Q1 2015.
- Funds reported $3.35B of Agios Pharmaceuticals stock for Q2 2015, up 27% quarter-over-quarter.
- 38 funds opened new Agios Pharmaceuticals positions in Q2 2015 and 28 closed out, a net change of +10 holders.
- The largest Agios Pharmaceuticals buyer in Q2 2015 was First Trust Advisors, an estimated $116M added.
- The largest Agios Pharmaceuticals seller in Q2 2015 was BlackRock Advisors, an estimated $39.5M sold.
Based on aggregated 13F filings for Q2 2015.